A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting Conditions
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the relative bioavailability of Propranolol
Hydrochloride Extended Release Capsules 160 mg (Actavis) with that of INDERAL® LA 160 mg
Capsules (Wyeth Pharmaceuticals) following a single oral dose (1 x 160 mg) in healthy adult
volunteers under non-fasting conditions.